ライフサイエンスコーパス: antinuclear antibody

1 ue, vague cognitive defects, and a low titer antinuclear antibody.

2 Three patients had a positive antinuclear antibody.

3 Sera were evaluated for the presence of antinuclear antibodies.

4 ive autoimmune B cells to produce pathogenic antinuclear antibodies.

5 , P-ANCA was associated with the presence of antinuclear antibodies.

6 mphoid organs spontaneously develop specific antinuclear antibodies.

7 thickening, and high titers of anti-DNA and antinuclear antibodies.

8 increased in humans and mice, combined with antinuclear antibodies.

9 dating autoantibody expression in SLE beyond antinuclear antibodies.

10 disease, such as arthritis, lymphopenia, or antinuclear antibodies.

11 hermore, about one-third of the mice develop antinuclear antibodies.

12 mes clinically detectable by the presence of antinuclear antibodies.

13 ), that are characterized by the presence of antinuclear antibodies.

14 c mice and was accompanied by an increase in antinuclear antibodies.

15 omenon (RP) and the presence of SSc-specific antinuclear antibodies.

16 ortion of autoreactive antibodies, including antinuclear antibodies.

17 immunofluorescence studies that demonstrate antinuclear antibodies.

18 tis and small joint involvement, and express antinuclear antibodies.

19 ts produced in vitro anti-GBM antibodies and antinuclear antibodies.

20 the majority of MZ twins are concordant for antinuclear antibodies.

21 cular dryness in the presence of circulating antinuclear antibodies.

22 Sera from 9/12 patients containing antinuclear antibodies (10/12 meeting diagnostic criteri

23 fold capillaroscopy and laboratory tests for antinuclear antibodies (ANA) and ANA subsets were obtain

24 indirect immunofluorescence assays to detect antinuclear antibodies (ANA) and antineutrophil cytoplas

25 ficient in this molecule develop spontaneous antinuclear antibodies (ANA) and fatal glomerulonephriti

26 in children may be associated with positive antinuclear antibodies (ANA) and may progress to systemi

27 say were compared with those of an assay for antinuclear antibodies (ANA) and with the severity of th

28 Antinuclear antibodies (ANA) are important in diagnosis

29 Screening only for antibodies to actin and antinuclear antibodies (ANA) failed to establish the dia

30 cted mixtures in relation to the presence of antinuclear antibodies (ANA), a widely used biomarker of

31 A majority of these autoantibodies are true antinuclear antibodies (ANA), and 50% of the ANAs are al

32 active protein, leukocyte count, presence of antinuclear antibodies (ANA), presence of human leukocyt

33 (NCWS), and investigated whether they carry antinuclear antibodies (ANA).

34 A locus Adnz1 on chromosome 4 was linked to antinuclear antibody (ANA) and anti-double stranded DNA

35 Here we report high titers of spontaneous antinuclear antibody (ANA) in C4(-/)- mice.

36 suggests that patients with in vivo speckled antinuclear antibody (ANA) patterns have high titers of

37 associations between mercury biomarkers and antinuclear antibody (ANA) positivity and titer strength

38 IA patients, including female preponderance, antinuclear antibody (ANA) positivity, and certain human

39 three positive answers were to attend for an antinuclear antibody (ANA) test; and those testing posit

40 orescence methods with bead-based assays for antinuclear antibody (ANA) testing is a new clinical opt

41 ected over a 5-year period in a rheumatology antinuclear antibody (ANA) testing laboratory.

42 A were identified, and serologic studies for antinuclear antibody (ANA), rheumatoid factor, and antib

43 DNA) and double-stranded DNA (anti-dsDNA) in antinuclear antibody (ANA)-positive type 1 autoimmune he

44 ic arthritis, spinal pain, fever, psoriasis, antinuclear antibodies [ANA], and rheumatoid factor).

45 E Disease Activity Index (SLEDAI), serology (antinuclear antibody [ANA] and anti-double-stranded (ds)

46 case-control study confirmed the presence of antinuclear antibodies (ANAs) and other autoantibodies i

47 IgG antinuclear antibodies (ANAs) are a feature of several a

48 Although antinuclear antibodies (ANAs) are detected in many autoi

49 Two outstanding questions concerning antinuclear antibodies (ANAs) in lupus involve their pat

50 nt (SLC-/-) mice harbored elevated levels of antinuclear antibodies (ANAs) in their serum and showed

51 s (SLE) is characterized by high-avidity IgG antinuclear antibodies (ANAs) that are almost certainly

52 ototypic autoimmune disease characterized by antinuclear antibodies (ANAs) that form immune complexes

53 Presence of antinuclear antibodies (ANAs) was also a risk factor for

54 The presence of antinuclear antibodies (ANAs) was determined using indir

55 -12 survey), laboratory parameters including antinuclear antibodies (ANAs), and SARS-CoV-2 antibody l

56 ti-citrullinated protein antibodies (ACPAs), antinuclear antibodies (ANAs), anti-tissue transglutamin

57 ototypic autoimmune disease characterized by antinuclear antibodies (ANAs), including pathogenic spec

58 bers according to the presence or absence of antinuclear antibodies (ANAs), the ANA staining patterns

59 systemic autoimmune disease characterized by antinuclear antibodies (ANAs).

60 in forming a pre-BCR, leads to production of antinuclear antibodies (ANAs).

61 yed a breached immune tolerance and secreted antinuclear antibodies (ANAs).

62 Antinuclear antibodies and AHAs, but not ssDNA abs, were

63 els, E6446 slowed development of circulating antinuclear antibodies and had a modest effect on anti-d

64 omparable in patients with and those without antinuclear antibodies and in both early- and late-onset

65 Female NZB/WF1 mice produce high titers of antinuclear antibodies and invariably succumb to severe

66 between fibromyalgia patients with low titer antinuclear antibodies and primary SS remains difficult.

67 Serum IgE, rheumatoid factor, and antinuclear antibodies and skin sensitivity to common al

68 itis, and laboratory abnormalities including antinuclear antibody and rheumatoid factor positivity.

69 SLE was based on the presence of arthritis, antinuclear antibodies, and double-stranded DNA, and a c

70 ore transplant of idiopathic cardiomyopathy, antinuclear antibodies, and HLA-B8, DR3 haplotypes.

71 ted diagnoses, discoid lupus, positivity for antinuclear antibodies, and/or false-positive syphilis t

72 Smooth muscle antibody, antinuclear antibody, and antibody to liver/kidney micro

73 presence of EBOV-specific immunoglobulin G, antinuclear antibodies, anti-cyclic citrullinated peptid

74 udies were similar, including positivity for antinuclear antibodies, anti-native DNA, and anti-double

75 ion markers included (1) autoimmunity signs (antinuclear antibody, antihistone antibody, antithyroglo

76 Antinuclear antibodies are a hallmark feature of general

77 Most polyreactive and antinuclear antibodies are removed from the human antibo

78 etric analysis of salivary glands, and serum antinuclear antibody assay were performed to assess vari

79 rbent assay, autoantigen proteome array, and antinuclear antibody assay.

80 These sera contained antinuclear antibodies, but lacked antibodies to double-

81 ed with the presence of rheumatoid factor or antinuclear antibodies, but not with positive allergen s

82 ccinee (n = 14), and one specimen containing antinuclear antibody cross-reacted with the assay.

83 C-reactive protein, rheumatoid factor, antinuclear antibody, cytoplasmic antineutrophil cytopla

84 Loci linked with anti-gp70 compared with antinuclear antibodies demonstrated the strongest linkag

85 to the drug developed in 8% of patients, and antinuclear antibodies developed in 2%.

86 en patients with (Ab(+)) and without (Ab(-)) antinuclear antibody during adulthood and an age- and se

87 Although SLE is characterized by antinuclear antibody expression, a significant proportio

88 This study explores the antinuclear antibody fine specificities and underlying c

89 ss offspring uncovered 5 suggestive loci for antinuclear antibody formation, consisting of 3 dominant

90 Sera containing antinuclear antibodies from patients with systemic lupus

91 regimen eluted severalfold more IgG and IgM antinuclear antibodies from the kidneys of nephritic SNF

92 n(KO) mice is characterized by production of antinuclear antibodies, glomerulonephritis, impaired B c

93 et of 321 serologically active SLE patients (antinuclear antibodies >/=1:80 and/or anti-double-strand

94 ly, H2(d/z) (compared with H2(d/d)) enhanced antinuclear antibodies in a coordinate fashion but did n

95 ther compounded by the finding of "positive" antinuclear antibodies in a high percent of the general

96 ssociations between selected xenobiotics and antinuclear antibodies in the National Health and Nutrit

97 hocytic infiltration of the lacrimal glands, antinuclear antibodies in the serum, and elevated titer

98 serum anti-CCP, rheumatoid factor (RF), and antinuclear antibody in a defined sample of 9,988 of bla

99 Two patients had positive antinuclear antibodies, including one with a history of

100 positive results because of the presence of antinuclear antibodies, is not a specific marker of anti

101 lambda(s) 11.0), anemia (lambda(s) 1.7), and antinuclear antibodies (lambda(s) 1.3).

102 Serologic markers showed increased IgG and antinuclear antibody levels in seven of 12 patients.

103 ers such as serum immunoglobulin G (IgG) and antinuclear antibody levels were available in 12 patient

104 active protein level, rheumatoid factor, and antinuclear antibody levels were within normal limits.

105 ith DSRD were more likely to have a positive antinuclear antibody, low complement 3, abnormal cytokin

106 Sera were tested using immunofluorescent antinuclear antibodies on HEp-2 cell slides, by anti-RNA

107 -like syndrome with joint manifestations and antinuclear antibodies: one had anti-RNP and antiphospho

108 sy-proven lupus nephritis in the presence of antinuclear antibodies or anti-double-stranded DNA antib

109 n-experienced autoreactive B cells producing antinuclear antibody or rheumatoid factor and exhibit th

110 All six patients had positive antinuclear antibody or smooth muscle antibody titers.

111 )/L: OR 2.15, 95% CI 1.63-2.83), presence of antinuclear antibodies (OR 2.87, 95% 1.57-5.24), and tre

112 ficantly associated with: i/ the presence of antinuclear antibodies (OR=5.9, P=0.04) ii/ a more sever

113 Analysis of his serum was negative for antinuclear antibody (or ANA), cytoplasmic antineutrophi

114 fferences in EBOV-specific immunoglobulin G, antinuclear antibody, or anti-cyclic citrullinated pepti

115 s (P = 0.01) and to have increased titers of antinuclear antibodies (P = 0.04).

116 before the diagnosis, were found later than antinuclear antibodies (P=0.06) and earlier than anti-nu

117 e weakness and congestive heart failure, was antinuclear antibody positive and had muscle biopsy find

118 Five children were antinuclear antibody positive.

119 on between the effects of rheumatoid factor, antinuclear antibodies, positive skin allergen tests, or

120 We selected 196 antinuclear antibody-positive adult SLE patients (age >

121 r, randomized, placebo-controlled trial, 819 antinuclear antibody-positive or anti-double-stranded DN

122 Seven antinuclear antibody-positive, nephritic female (SWR x N

123 most frequent combination was arthritis and antinuclear antibody positivity followed by malar rash a

124 llin 1 antibodies and active skin disease or antinuclear antibody positivity were found.

125 Antinuclear antibody positivity, early onset of disease,

126 subjects in this cohort had similar rates of antinuclear antibody positivity, whereas lupus-specific

127 We further demonstrate antinuclear antibody production is influenced by the pre

128 However, antinuclear antibody production was increased compared w

129 dermatomyositis, the mice developed a strong antinuclear antibody response, characteristic of autoimm

130 ash, autoimmune thyroiditis, the presence of antinuclear antibodies, sinopulmonary infections, and co

131 Serum analysis was negative for antinuclear antibody, Sjogren syndrome antigens A and B,

132 range of autoantibodies (rheumatoid factor, antinuclear antibody, smooth muscle autoantibody, mitoch

133 Antinuclear antibody status was a predictor for the deve

134 Male sex, independent of age or antinuclear antibody status, is associated with increase

135 Antinuclear antibodies test results were negative.

136 The indirect fluorescence antinuclear antibody test on Hep-2 cells demonstrated an

137 Routine antinuclear antibody testing has a low positive predicti

138 ccordingly, the positive predictive value of antinuclear antibody testing in diagnosing SLE in a pati

139 is needed to establish the value of routine antinuclear antibody testing in patients with uveitis.

140 The positive predictive value of routine antinuclear antibody testing was 2.9% (95% CI, 2.65%-3.1

141 Routine antinuclear antibody testing, for example, is not recomm

142 e negative for anti-SSA/Ro, anti-SSB/La, and antinuclear antibodies than women (36% men vs 11% women,

143 up (71.5%) of serologically active patients (antinuclear antibody titer >/=1:80 and/or anti-double-st

144 ents with lcSSc or Raynaud's syndrome and an antinuclear antibody typical of lcSSc as part of the bas

145 elet volume, positive rheumatoid factor, and antinuclear antibodies were all significantly more preva

146 s syndrome with high levels of antineural or antinuclear antibodies were infused bilaterally into the

147 Antinuclear antibodies were present at low titers in 4 p

148 Antinuclear antibodies were present in 23 (69.9%) of pat

149 Antinuclear antibodies were present in 4 of 55 sera test

150 Antinuclear antibodies were present in 78 percent (at a

151 Antinuclear antibodies were present in all patients.

152 nofluorescence immunoreactants and low titer antinuclear antibodies were variably present.

153 s with systemic autoimmune disease featuring antinuclear antibodies with IgG4 elevation uncovered an